JILL STANDLEY: Open Payments
NPI 1235762774 · CLARKSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 15 payments from 7 companies in 2025. Trend: 2023 $188 · 2024 $142 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $138 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
Products named: VRAYLAR, Qelbree, HETLIOZ, INGREZZA, CAPLYTA, UBRELVY, REXULTI, Dexcom G6 Transmitter.
Industry payments across TN — which companies pay providers there.
